Traders purchased shares of Express Scripts Holding (NASDAQ:ESRX) on weakness during trading on Tuesday following insider selling activity. $87.42 million flowed into the stock on the tick-up and $71.77 million flowed out of the stock on the tick-down, for a money net flow of $15.65 million into the stock. Of all equities tracked, Express Scripts had the 31st highest net in-flow for the day. Express Scripts traded down ($0.57) for the day and closed at $72.42Specifically, insider Christine Houston sold 19,889 shares of the business’s stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $76.69, for a total value of $1,525,287.41. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Glen D. Stettin sold 3,448 shares of the business’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The disclosure for this sale can be found here. Insiders sold a total of 31,681 shares of company stock worth $2,435,102 over the last three months. 0.68% of the stock is currently owned by corporate insiders.
A number of equities analysts have recently weighed in on ESRX shares. Maxim Group upped their price target on shares of Express Scripts from $78.00 to $87.00 and gave the stock a “buy” rating in a research note on Thursday, December 14th. Deutsche Bank started coverage on shares of Express Scripts in a research note on Monday, December 4th. They set a “buy” rating and a $75.00 price target on the stock. Zacks Investment Research cut shares of Express Scripts from a “buy” rating to a “hold” rating in a research note on Friday, March 2nd. SunTrust Banks set a $86.00 price target on shares of Express Scripts and gave the stock a “buy” rating in a research note on Thursday, December 21st. Finally, TheStreet raised shares of Express Scripts from a “c+” rating to a “b-” rating in a research note on Monday, December 4th. Three equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and six have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $81.97.
The company has a quick ratio of 0.55, a current ratio of 0.67 and a debt-to-equity ratio of 0.83. The firm has a market cap of $42,665.23, a PE ratio of 9.25, a P/E/G ratio of 0.93 and a beta of 0.94.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, February 27th. The company reported $2.16 EPS for the quarter, topping the consensus estimate of $2.09 by $0.07. Express Scripts had a net margin of 4.51% and a return on equity of 25.19%. The business had revenue of $25.38 billion for the quarter, compared to analyst estimates of $25.07 billion. During the same period in the previous year, the firm earned $1.88 EPS. The business’s revenue for the quarter was up 2.1% compared to the same quarter last year. equities analysts forecast that Express Scripts Holding will post 9.35 earnings per share for the current fiscal year.
Express Scripts announced that its board has approved a stock repurchase program on Monday, December 18th that allows the company to repurchase 45,000,000 outstanding shares. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.
Several institutional investors have recently added to or reduced their stakes in the stock. Bank of New York Mellon Corp lifted its holdings in Express Scripts by 8.7% in the 4th quarter. Bank of New York Mellon Corp now owns 8,287,905 shares of the company’s stock valued at $618,609,000 after purchasing an additional 666,754 shares in the last quarter. Nordea Investment Management AB lifted its holdings in Express Scripts by 2.6% in the 3rd quarter. Nordea Investment Management AB now owns 7,304,973 shares of the company’s stock valued at $462,551,000 after purchasing an additional 188,528 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Express Scripts by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,608,383 shares of the company’s stock valued at $492,297,000 after purchasing an additional 32,548 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in Express Scripts by 1.3% in the 3rd quarter. Dimensional Fund Advisors LP now owns 6,545,076 shares of the company’s stock valued at $414,419,000 after purchasing an additional 86,800 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its holdings in Express Scripts by 23.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock valued at $331,374,000 after purchasing an additional 996,816 shares in the last quarter. Institutional investors and hedge funds own 89.44% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://ledgergazette.com/2018/03/20/investors-buy-express-scripts-esrx-on-weakness-after-insider-selling.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.